Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Bio Essence (BIOE) Receivables - Other (2022 - 2024)

Bio Essence has reported Receivables - Other over the past 3 years, most recently at $197294.0 for Q3 2024.

  • For Q3 2024, Receivables - Other changed N/A year-over-year to $197294.0; the TTM value through Sep 2024 reached $197294.0, changed N/A, while the annual FY2023 figure was $710084.0, 17.41% up from the prior year.
  • Receivables - Other for Q3 2024 was $197294.0 at Bio Essence, roughly flat from $197294.0 in the prior quarter.
  • Over five years, Receivables - Other peaked at $710084.0 in Q4 2023 and troughed at $197294.0 in Q2 2024.
  • A 3-year average of $391231.6 and a median of $246701.0 in 2024 define the central range for Receivables - Other.
  • On a YoY basis, Receivables - Other climbed as much as 17.41% in 2023 and fell as far as 17.41% in 2023.
  • Year by year, Receivables - Other stood at $604785.0 in 2022, then rose by 17.41% to $710084.0 in 2023, then plummeted by 72.22% to $197294.0 in 2024.
  • Business Quant data shows Receivables - Other for BIOE at $197294.0 in Q3 2024, $197294.0 in Q2 2024, and $246701.0 in Q1 2024.